{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":5,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":5,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"592b5e7f5b1c","filters":{"venue":"Current Drug Targets - Infectious Disorders"}},"results":[{"id":"W2166290770","doi":"10.2174/1568005024605855","title":"Clinical Development of Cationic Antimicrobial Peptides: From Natural to Novel Antibiotics","year":2002,"lang":"en","type":"review","venue":"Current Drug Targets - Infectious Disorders","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":368,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Canada Research Chairs; Cystic Fibrosis Foundation","keywords":"Antimicrobial; Antibiotics; Antimicrobial peptides; Cationic polymerization; Biology; Microbiology; Computational biology; Chemistry; Organic chemistry","authors":[{"name":"Rebecca Hancock","is_ca":true},{"name":"Aleksander Patrzykat","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03686783319529565,"gpt":0.3270290480160197,"spread":0.2901612148207241,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007619773,0.0005871209,0.000738588,0.001352243,0.0001830673,0.0009185178,0.0006486375,0.000946369,0.002666374],"category_scores_gemma":[0.0004897749,0.0002084464,0.000228283,0.000774909,0.0004169857,0.0009774575,0.0004833317,0.001112576,0.002367181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005302423,"about_ca_system_score_gemma":0.0005727545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002143269,"about_ca_topic_score_gemma":0.0004320341,"domain_scores_codex":[0.9997787,0.00003887389,0.00002222,0.00003111101,0.0001032567,0.0000259431],"domain_scores_gemma":[0.9998298,0.00005527437,0.000024395,0.000007408009,0.00004697973,0.00003606771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001511799,0.0001911277,0.0002590652,0.003272191,0.00002889127,0.0004688597,0.0000853344,0.0004090026,0.01232672,0.004658141,0.01173712,0.9664125],"study_design_scores_gemma":[0.0001050468,0.0005464529,0.0007840506,0.0009021127,0.00002691629,0.002704965,0.0000589768,0.0001882374,0.005791396,0.002068355,0.9868076,0.00001592206],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001645861,0.9922593,0.00126515,0.0007245403,0.0002906837,0.00002485647,0.00001617507,0.00003192559,0.003741511],"genre_scores_gemma":[0.009221815,0.9844557,0.001813944,0.0007352001,0.0003821027,0.00004114677,0.00005136047,0.000005888942,0.003292812],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002666374,"threshold_uncertainty_score":0.008919954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052987107","doi":"10.2174/1568005014606143","title":"Lipopolysaccharide as a Target for the Development of Novel Therapeutics in Gram-Negative Bacteria","year":2001,"lang":"en","type":"review","venue":"Current Drug Targets - Infectious Disorders","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Guelph","funders":"","keywords":"Lipopolysaccharide; Gram-negative bacteria; Lipid A; Bacteria; Biosynthesis; Function (biology); In vitro; Computational biology; Biology; Chemistry; Biochemistry; Microbiology; Cell biology; Escherichia coli; Immunology; Enzyme; Genetics","authors":[{"name":"Jeremy A. Yethon","is_ca":true},{"name":"Christopher Whitfield","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03574007799130596,"gpt":0.3414995194850012,"spread":0.3057594414936952,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002882589,0.0005965886,0.0008443149,0.000957887,0.000272955,0.0006834731,0.0004594112,0.0008825908,0.003773063],"category_scores_gemma":[0.0001868567,0.0001489034,0.000214307,0.0009545657,0.0002851091,0.000940085,0.0003240022,0.0008835719,0.003999731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004552302,"about_ca_system_score_gemma":0.0005447948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003439372,"about_ca_topic_score_gemma":0.0006337019,"domain_scores_codex":[0.99991,0.00001759386,0.000009079133,0.00001411955,0.00003951875,0.000009611917],"domain_scores_gemma":[0.9999346,0.00001926673,0.00000940954,0.00000332427,0.00002078916,0.00001269507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001784704,0.000164571,0.0002257155,0.008406192,0.00004594374,0.0008762871,0.0000962771,0.0005711014,0.03120026,0.008601761,0.01925792,0.9303756],"study_design_scores_gemma":[0.00003816443,0.0002653842,0.0007591327,0.001169835,0.00005489241,0.002908304,0.0000777632,0.0001905414,0.005493764,0.002834646,0.9861921,0.00001553183],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009868592,0.9940187,0.00077641,0.0004659062,0.0003384699,0.00001288346,0.00002083071,0.0000202323,0.003359678],"genre_scores_gemma":[0.003624108,0.9914576,0.001052525,0.0002795048,0.0001750258,0.00001855443,0.00004938754,0.000003226057,0.003340036],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003773063,"threshold_uncertainty_score":0.01262218,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000122784","doi":"10.2174/1568005053174609","title":"Advances on Cyclin-dependent Kinases (CDKs) as Novel Targets for Antiviral Drugs","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - Infectious Disorders","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Heritage Medical Research Clinic","funders":"","keywords":"Cyclin-dependent kinase; Biology; Antiviral drug; Viral replication; Kinase; Virology; Drug discovery; Drug resistance; Virus; Cancer; Bioinformatics; Cell cycle; Cell biology; Genetics","authors":[{"name":"Luis M. Schang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02372620439308413,"gpt":0.3544776896726562,"spread":0.3307514852795721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000975113,0.0007642574,0.0009462427,0.001089398,0.0002899811,0.00108938,0.000533845,0.0008108778,0.002495492],"category_scores_gemma":[0.0005746344,0.0003171152,0.0007762556,0.0007728603,0.0005894338,0.001538702,0.0007837557,0.002838694,0.001178128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009308436,"about_ca_system_score_gemma":0.0007762563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005899654,"about_ca_topic_score_gemma":0.001063953,"domain_scores_codex":[0.9996676,0.00007716702,0.00002801791,0.00007523926,0.00009532873,0.00005666319],"domain_scores_gemma":[0.9996333,0.0001391117,0.00004353717,0.00002385394,0.0001059818,0.00005425889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007356047,0.0005607634,0.001274809,0.007263565,0.0001565094,0.0006283433,0.0002663647,0.002041173,0.08423444,0.04442147,0.02297548,0.8354415],"study_design_scores_gemma":[0.0001973557,0.001163745,0.00201004,0.0006642984,0.000276615,0.001452396,0.0001051698,0.002407479,0.04114363,0.01058334,0.9399298,0.00006613104],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008293686,0.9677554,0.008664001,0.003291587,0.0007811299,0.00005929007,0.0001071771,0.0000968105,0.0109509],"genre_scores_gemma":[0.0583238,0.9223046,0.01076627,0.001963917,0.0009335345,0.00009859398,0.0002850412,0.0000275131,0.005296692],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002495492,"threshold_uncertainty_score":0.008348286,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2082634748","doi":"10.2174/1568005014606017","title":"History of Vaccines and Positioning of Current Trends","year":2001,"lang":"en","type":"article","venue":"Current Drug Targets - Infectious Disorders","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovative Medicines Canada","funders":"","keywords":"Milestone; Civilization; Infectious disease (medical specialty); Medicine; Virology; Disease; Political science; History; Pathology","authors":[{"name":"Paul Payette","is_ca":true},{"name":"Heather L. Davis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01811441038436491,"gpt":0.2885642788367619,"spread":0.270449868452397,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01469849,0.0005205237,0.0007714108,0.002921111,0.001344742,0.006201739,0.0009777099,0.002793283,0.006755937],"category_scores_gemma":[0.02064406,0.0003338983,0.0002895485,0.003640118,0.004965517,0.007278671,0.001875566,0.005200255,0.00154703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005364698,"about_ca_system_score_gemma":0.00503473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002547867,"about_ca_topic_score_gemma":0.002365972,"domain_scores_codex":[0.9946497,0.002661208,0.0006257399,0.0005113285,0.001246819,0.0003052851],"domain_scores_gemma":[0.9804634,0.01138665,0.001247065,0.0007128958,0.004461608,0.001728346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006247465,0.0001954568,0.004905133,0.004333781,0.00007343391,0.0003798055,0.001788535,0.0007056035,0.001230769,0.2224524,0.08593446,0.6773759],"study_design_scores_gemma":[0.00002218395,0.0002232162,0.002248435,0.002222469,0.00003090239,0.0003129442,0.0007383772,0.000113254,0.0005317373,0.02876459,0.9647653,0.00002665091],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004864532,0.7555155,0.002738994,0.1781103,0.009127554,0.00005879572,0.0002209276,0.0000655346,0.0492979],"genre_scores_gemma":[0.08368655,0.8405284,0.004709701,0.0425734,0.01481132,0.0001333022,0.0003049801,0.00008346635,0.01316892],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01469849,"threshold_uncertainty_score":0.07773399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2081852455","doi":"10.2174/1568005023342362","title":"Strategic Targeting of Essential Host-pathogen Interactions in Chlamydial Disease","year":2002,"lang":"en","type":"review","venue":"Current Drug Targets - Infectious Disorders","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Chlamydiae; Biology; Intracellular parasite; Pathogen; Chlamydia; Virulence; Microbiology; Chlamydia trachomatis; Human pathogen; Intracellular; Virology; Immunology; Bacteria; Gene; Genetics","authors":[{"name":"Brian K. Coombes","is_ca":true},{"name":"D. R. Johnson","is_ca":false},{"name":"James B. Mahony","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04407964193876839,"gpt":0.3571612964300273,"spread":0.3130816544912589,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000398774,0.0006434461,0.000867449,0.0009123455,0.0003089713,0.0006594449,0.0005651378,0.001015367,0.00231326],"category_scores_gemma":[0.0002408237,0.0001973803,0.0002096483,0.0009198403,0.0003599699,0.0008031601,0.000331466,0.000735686,0.001876348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006305177,"about_ca_system_score_gemma":0.000643036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006203889,"about_ca_topic_score_gemma":0.001283678,"domain_scores_codex":[0.999877,0.00003047022,0.0000127995,0.00001651145,0.00004714627,0.00001607662],"domain_scores_gemma":[0.9999229,0.00002770437,0.00001041126,0.000004433592,0.00002144557,0.00001320883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000176879,0.0001457881,0.0003080159,0.006489538,0.00003622514,0.0006786309,0.00007707971,0.0006054368,0.02377895,0.006810554,0.01090611,0.9499868],"study_design_scores_gemma":[0.00006136703,0.0004576755,0.00174968,0.001099085,0.00006456202,0.003773549,0.0001006121,0.0002037948,0.01015626,0.002911866,0.9794014,0.00002014512],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001219359,0.9940305,0.0008287367,0.0003484564,0.0002059783,0.000013156,0.00001546843,0.00002209701,0.003316174],"genre_scores_gemma":[0.006336432,0.9892493,0.001187323,0.0002549355,0.0001090203,0.00002004946,0.00002914598,0.000003451011,0.002810276],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00231326,"threshold_uncertainty_score":0.00773859,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}